Physician profile
Raisa M Uddin
NPI 1285121038
$281.08
in general payments reported to CMS, 2019-2025
12 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $115 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $53.63 | 2024 | |
| Biocryst US Sales Co., LLC | $25.36 | 2025 | Orladeyo |
| Regeneron Healthcare Solutions, INC. | $24.82 | 2025 | Dupixent |
| Sanofi Pasteur INC. | $23.46 | 2025 | |
| Seqirus USA INC | $22.63 | 2025 | Flucelvax |
| Astrazeneca Pharmaceuticals LP | $22.34 | 2024 | Flumist Quadrivalent |
| Sobi, INC | $21.12 | 2024 | |
| Cranial Technologies, INC | $18.89 | 2025 | Doc Band |
| Pfizer INC. | $17.51 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $17.51 | 2025 | Zoryve |
| Merck Sharp & Dohme LLC | $17.07 | 2025 | Gardasil 9, Enflonsia |
| Collegium Pharmaceutical, INC. | $16.74 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raisa Uddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.